Psychiatry and Neurology, Neurology · Boston, MA
NPI
1124223318
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
55 Fruit St, Wang 735
Boston, MA, 02114
Phone (617) 726-1067
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
269 services
Medicare patients, 2024
103
Average age 69
Drug cost, 2024
$463K
1,037 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mouhsin Shafi was code 95720 (neurologic), 77 times for 33 patients. In total Mouhsin Shafi billed 269 services in 26 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 77 | 33 | $172.72 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 37 | 33 | $11.93 | $442 |
| 99214 Office E&M - Established | Facility | 24 | 22 | $71.17 | $1,708 |
| 95718 Neurologic | Facility | 20 | 20 | $112.25 | $2,245 |
| 99213 Office E&M - Established | Facility | 12 | 11 | $36.71 | $440 |
By year: 2022 $38K for 273 services; 2023 $33K for 264 services; 2024 $27K for 269 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mouhsin Shafi prescribed most often to Medicare patients was Lacosamide, with 137 prescriptions and refills. In total Mouhsin Shafi wrote 1,037 Medicare prescriptions that cost $463K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 137 | 167 | 19 | $8,825 |
| Lamotrigine Generic | 114 | 188 | 14 | $2,297 |
| Levetiracetam Generic | 89 | 175 | 22 | $2,790 |
| Xcopri Cenobamate | 62 | 62 | Under 11 | $75K |
| Phenobarbital Generic | 57 | 65 | Under 11 | $1,590 |
| Lamotrigine Er Lamotrigine | 47 | 92 | Under 11 | $10K |
| Zonisamide Generic | 40 | 70 | Under 11 | $1,667 |
| Clobazam Generic | 32 | 40 | Under 11 | $1,072 |
| Lorazepam Generic | 32 | 32 | Under 11 | $313 |
| Lamictal Lamotrigine | 31 | 49 | Under 11 | $64K |
| Gabapentin Generic | 31 | 39 | Under 11 | $653 |
| Divalproex Sodium Generic | 30 | 30 | Under 11 | $473 |
| Oxcarbazepine Generic | 25 | 45 | Under 11 | $1,167 |
| Briviact Brivaracetam | 24 | 24 | Under 11 | $35K |
| Carbamazepine Er Carbamazepine | 22 | 38 | Under 11 | $2,611 |
Brand drugs: 229 claims; generic drugs: 751 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mouhsin Shafi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.